Immunome Inc (NASDAQ: IMNM) — Healthcare · Share Price, Chart & Market Data
About: Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $23.56 (+2.48%)
IMNMImmunome Inc
Loading watchlist status…
Trade IMNM now
Immunome Inc share price
IMNM price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:15 pm GMT+0
IMNM price performance
-1.216%
5D
20.143%
1M
13.16%
YTD
174.592%
1Y
IMNM price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:15 pm GMT+0
IMNM details
IMNM Market Signals